Phibro Animal Health PAHC
NASDAQ PAHC
$34.45 -0.85 (-2.41%)
As of: Sep 17, 2026 · 3:59 PM EDT

Phibro Animal Health (PAHC) Accumulated Expenses (2013 - 2026)

Phibro Animal Health (PAHC) posted Accumulated Expenses of $164.1 million for Q2 2026, up 26.84% on a QoQ basis from $129.4 million in Q1 2026, and up 18.06% year-over-year from $139.0 million in Q2 2025.

Analysis

Phibro Animal Health (PAHC) Accumulated Expenses (2013 - 2026) Analysis & Trends

Phibro Animal Health has reported Accumulated Expenses for 14 years, with the latest figure at $164.1 million in Q2 2026.

  • On a quarterly basis, Accumulated Expenses rose 18.06% year-over-year to $164.1 million in Q2 2026; TTM through Jun 2026 was $164.1 million, a 18.06% increase from a year earlier, with the FY2026 full-year figure at $164.1 million, up 18.06% from the prior year.
  • Accumulated Expenses was $164.1 million for Q2 2026 at Phibro Animal Health, up from $129.4 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $164.1 million in Q2 2026, with the low at $68.7 million in Q3 2022.
  • Average Accumulated Expenses over 5 years is $98.3 million, with a median of $82.6 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Accumulated Expenses decreased 10.06% in 2023, then soared 56.58% in 2025.
  • Over 5 years, Accumulated Expenses stood at $71.7 million in 2022, then gained by 5.05% to $75.3 million in 2023, then soared by 56.16% to $117.6 million in 2024, then grew by 9.26% to $128.4 million in 2025, then increased by 27.79% to $164.1 million in 2026.
  • The last three Accumulated Expenses figures came in at $164.1 million (Q2 2026), $129.4 million (Q1 2026), and $128.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 40.57 Bn 40.38 Bn 779.09 Mn
2 Zoetis 30.57 Bn 28.90 Bn 1.05 Bn
3 Elanco Animal Health 11.47 Bn 10.94 Bn 798.00 Mn
4 Phibro Animal Health 1.43 Bn 1.35 Bn 134.40 Mn
5 Immucell 87.38 Mn 78.52 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 64.40 Mn 57.30 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 164.13 Mn
Mar 31, 2026 129.40 Mn
Dec 31, 2025 128.44 Mn
Sep 30, 2025 121.10 Mn
Jun 30, 2025 139.02 Mn
Mar 31, 2025 118.61 Mn
Dec 31, 2024 117.56 Mn
Sep 30, 2024 82.87 Mn
Jun 30, 2024 88.79 Mn
Mar 31, 2024 76.65 Mn
Dec 31, 2023 75.28 Mn
Sep 30, 2023 70.99 Mn
Jun 30, 2023 79.85 Mn
Mar 31, 2023 74.12 Mn
Dec 31, 2022 71.66 Mn
Sep 30, 2022 68.70 Mn
Jun 30, 2022 80.24 Mn
Mar 31, 2022 82.41 Mn
Dec 31, 2021 72.84 Mn
Sep 30, 2021 74.53 Mn